These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

160 related articles for article (PubMed ID: 36642947)

  • 1. Effect of Bevacizumab Treatment in Cerebral Radiation Necrosis : Investigation of Response Predictors in a Single-Center Experience.
    Lee SH; Choi JW; Kong DS; Seol HJ; Nam DH; Lee JI
    J Korean Neurosurg Soc; 2023 Sep; 66(5):562-572. PubMed ID: 36642947
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Bevacizumab as a treatment for radiation necrosis of brain metastases post stereotactic radiosurgery.
    Boothe D; Young R; Yamada Y; Prager A; Chan T; Beal K
    Neuro Oncol; 2013 Sep; 15(9):1257-63. PubMed ID: 23814264
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Low-Dosage Bevacizumab Treatment: Effect on Radiation Necrosis After Gamma Knife Radiosurgery for Brain Metastases.
    Weng Y; Shen J; Zhang L; Fang Z; Xiao F; Zhang C; Fan Z; Huang K; Wang L; Huang B; Wu F; Zhang T; Xu Q
    Front Surg; 2021; 8():720506. PubMed ID: 34540887
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Bevacizumab is an effective treatment for symptomatic cerebral necrosis after carbon ion therapy for recurrent intracranial malignant tumours: A case report.
    Liu R; Luo H; Zhang Q; Sun S; Liu Z; Wang X; Geng Y; Zhao X
    Mol Clin Oncol; 2022 Jul; 17(1):114. PubMed ID: 35747599
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Blood-Brain Barrier Repair of Bevacizumab and Corticosteroid as Prediction of Clinical Improvement and Relapse Risk in Radiation-Induced Brain Necrosis: A Retrospective Observational Study.
    Xue R; Chen M; Cai J; Deng Z; Pan D; Liu X; Li Y; Rong X; Li H; Xu Y; Shen Q; Tang Y
    Front Oncol; 2021; 11():720417. PubMed ID: 34692494
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Bevacizumab as a treatment for radiation necrosis following stereotactic radiosurgery for brain metastases: clinical and radiation dosimetric impacts.
    Li J; He J; Cai L; Lai M; Hu Q; Ren C; Wen L; Wang J; Zhou J; Zhou Z; Li S; Ye M; Shan C; Chen L; Zhou C
    Ann Palliat Med; 2021 Feb; 10(2):2018-2026. PubMed ID: 33549015
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Clinical Variables for Prediction of the Therapeutic Effects of Bevacizumab Monotherapy in Nasopharyngeal Carcinoma Patients With Radiation-Induced Brain Necrosis.
    Li Y; Huang X; Jiang J; Hu W; Hu J; Cai J; Rong X; Cheng J; Xu Y; Wu R; Luo J; Tang Y
    Int J Radiat Oncol Biol Phys; 2018 Mar; 100(3):621-629. PubMed ID: 29413276
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Targeted intraarterial anti-VEGF therapy for medically refractory radiation necrosis in the brain.
    Dashti SR; Spalding A; Kadner RJ; Yao T; Kumar A; Sun DA; LaRocca R
    J Neurosurg Pediatr; 2015 Jan; 15(1):20-5. PubMed ID: 25360851
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Single low-dose targeted bevacizumab infusion in adult patients with steroid-refractory radiation necrosis of the brain: a phase II open-label prospective clinical trial.
    Dashti SR; Kadner RJ; Folley BS; Sheehan JP; Han DY; Kryscio RJ; Carter MB; Shields LBE; Plato BM; La Rocca RV; Spalding AC; Yao TL; Fraser JF
    J Neurosurg; 2022 Dec; 137(6):1676-1686. PubMed ID: 35426830
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Bevacizumab treatment leads to observable morphological and metabolic changes in brain radiation necrosis.
    Yonezawa S; Miwa K; Shinoda J; Nomura Y; Asano Y; Nakayama N; Ohe N; Yano H; Iwama T
    J Neurooncol; 2014 Aug; 119(1):101-9. PubMed ID: 24789256
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Treatment of cerebral radiation necrosis with bevacizumab: the Cleveland clinic experience.
    Sadraei NH; Dahiya S; Chao ST; Murphy ES; Osei-Boateng K; Xie H; Suh JH; Peereboom DM; Stevens GH; Ahluwalia MS
    Am J Clin Oncol; 2015 Jun; 38(3):304-10. PubMed ID: 23799286
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Bevacizumab for radiation necrosis following radiotherapy of brain metastatic disease: a systematic review & meta-analysis.
    Khan M; Zhao Z; Arooj S; Liao G
    BMC Cancer; 2021 Feb; 21(1):167. PubMed ID: 33593308
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Bevacizumab Monotherapy Reduces Radiation-induced Brain Necrosis in Nasopharyngeal Carcinoma Patients: A Randomized Controlled Trial.
    Xu Y; Rong X; Hu W; Huang X; Li Y; Zheng D; Cai Z; Zuo Z; Tang Y
    Int J Radiat Oncol Biol Phys; 2018 Aug; 101(5):1087-1095. PubMed ID: 29885994
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Clinical Experience of Bevacizumab for Radiation Necrosis in Patients with Brain Metastasis.
    Park M; Gwak HS; Lee SH; Lee YJ; Kwon JW; Shin SH; Yoo H
    Brain Tumor Res Treat; 2020 Oct; 8(2):93-102. PubMed ID: 32648383
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Bevacizumab: radiation combination produces restricted diffusion on brain MRI.
    Hesselink JR; Barkovich MJ; Seibert TM; Farid N; Muller KA; Murphy KT; Kesari S
    CNS Oncol; 2014; 3(5):329-35. PubMed ID: 25363005
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Bevacizumab for the Treatment of Radiation-Induced Cerebral Necrosis: A Systematic Review of the Literature.
    Delishaj D; Ursino S; Pasqualetti F; Cristaudo A; Cosottini M; Fabrini MG; Paiar F
    J Clin Med Res; 2017 Apr; 9(4):273-280. PubMed ID: 28270886
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Bevacizumab for radiation necrosis following treatment of high grade glioma: a systematic review of the literature.
    Lubelski D; Abdullah KG; Weil RJ; Marko NF
    J Neurooncol; 2013 Dec; 115(3):317-22. PubMed ID: 24005770
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Bevacizumab-induced diffusion-restricted lesions in malignant glioma patients.
    Rieger J; Bähr O; Müller K; Franz K; Steinbach J; Hattingen E
    J Neurooncol; 2010 Aug; 99(1):49-56. PubMed ID: 20035366
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cerebral blood volume and apparent diffusion coefficient - Valuable predictors of non-response to bevacizumab treatment in patients with recurrent glioblastoma.
    Petrova L; Korfiatis P; Petr O; LaChance DH; Parney I; Buckner JC; Erickson BJ
    J Neurol Sci; 2019 Oct; 405():116433. PubMed ID: 31476621
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Re-irradiation for recurrent high-grade glioma: an analysis of prognostic factors for survival and predictors of radiation necrosis.
    Moore-Palhares D; Chen H; Keith J; Wang M; Myrehaug S; Tseng CL; Detsky J; Perry J; Lim-Fat MJ; Heyn C; Maralani P; Lipsman N; Das S; Sahgal A; Soliman H
    J Neurooncol; 2023 Jul; 163(3):541-551. PubMed ID: 37256526
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.